Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02967822 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT02967822 · ClinicalTrials.gov record · last posted 2018-10-12

Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome

Study acronym: MRKH
StatusRecruiting
PhaseNot specified
Started2016-05
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly. Toward this goal, the research team would like to include in the study patients with MRKH syndrome, as well as their healthy relatives, in order to perform genetic analyses, especially whole exome sequencing. This study has been set up in order to collect biological samples from patients with MRKH and their relatives.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2016-11-17; most recent amendment 2018-10-10. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT02967822
Lead Sponsor Imagine Institute
Collaborators: Reference center for rare diseases (Rare Gynecologic Diseases)
Conditions Mayer Rokitansky Kuster Hauser Syndrome
Enrollment 410 participants
Start Date 2016-05
Primary Completion 2031-05 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2018-10-12